poisar

Stock

Sight Sciences, Inc. SGHT

$8.43+0.78%

Overview

SGHT market data

Price History

SGHT price chart · 1M
O
8.31
H
8.53
L
8.28
C
8.43
Vol
9,009.00
Source
US equities market feed
Observed
Aug 27, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$8.31
Previous Close
$8.37
Day High
$8.53
Day Low
$8.28
52 Week High
$8.84
52 Week Low
$3.87
7 Day Return
+3.44%
30 Day Return
+58.76%
90 Day Return
+72.92%
1 Year Return
+112.61%
Daily Notional Volume
$75.9K
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$0.74
Diluted earnings per share over the trailing twelve months.
Beta
2.48
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-35.7%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$3.19 – $9.24
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $458.3M · P/B 6.56 · P/S 5.50.

Company News

9 captured
Sight Sciences Announces Updated FDA Indications For TearCare, Effective August 18Benzinga · Aug 19, 2026, 11:10 AM
8-K filing — Sight Sciences, Inc. (SGHT)SEC EDGAR · Aug 10, 2026, 12:21 PM
UBS Maintains Buy on Sight Sciences, Raises Price Target to $8Benzinga · Aug 6, 2026, 7:40 PM
Sight Sciences Raises FY2026 Sales Guidance from $83.000M-$89.000M to $88.000M-$92.000M vs $86.083M EstBenzinga · Aug 5, 2026, 8:35 PM
Sight Sciences Q2 EPS $(0.08) Beats $(0.15) Estimate, Sales $23.388M Beat $21.682M EstimateBenzinga · Aug 5, 2026, 8:12 PM
Why Arista Networks Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving PremarketBenzinga · Aug 5, 2026, 8:57 AM
Sight Sciences Receives FDA 510(k) Clearance For OMNI Ultra Surgical System; Next-Generation Implant-Free MIGS Device For Primary Open-Angle GlaucomaBenzinga · Aug 4, 2026, 9:39 PM
Citigroup Maintains Neutral on Sight Sciences, Raises Price Target to $6Benzinga · Jul 8, 2026, 3:50 PM
Citigroup Maintains Neutral on Sight Sciences, Raises Price Target to $5.15Benzinga · May 28, 2026, 8:07 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock